Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

EPRATUZUMAB
(D04036)

[1] Epratuzumab

[1] Epratuzumab (D04036) 💬

[1] CD22 💬

[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬

[1] 49 💬

2

Epratuzumab 100 mg
(D04036)

[1] Epratuzumab

[1] Epratuzumab (D04036) 💬

[1] CD22 💬

[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬

[1] 49 💬

3

Epratuzumab 1200 mg
(D04036)

[1] Epratuzumab

[1] Epratuzumab (D04036) 💬

[1] CD22 💬

[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬

[1] 49 💬

4

Epratuzumab 400 mg
(D04036)

[1] Epratuzumab

[1] Epratuzumab (D04036) 💬

[1] CD22 💬

[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬

[1] 49 💬

5

Epratuzumab 600 mg
(D04036)

[1] Epratuzumab

[1] Epratuzumab (D04036) 💬

[1] CD22 💬

[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬

[1] 49 💬

6

Epratuzumab iv
(D04036)

[1] Epratuzumab

[1] Epratuzumab (D04036) 💬

[1] CD22 💬

[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬

[1] 49 💬

7

Epratuzumab sc
(D04036)

[1] Epratuzumab

[1] Epratuzumab (D04036) 💬

[1] CD22 💬

[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬

[1] 49 💬

8

HLL2 (Epratuzumab)
(D04036)

[1] Epratuzumab

[1] Epratuzumab (D04036) 💬

[1] CD22 💬

[3] B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬

[1] 49 💬